Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements

被引:0
|
作者
S Sitailo
R Sood
K Barton
G Nucifora
机构
[1] Loyola University Medical Center,Oncology Institute and Department of Medicine
来源
Leukemia | 1999年 / 13卷
关键词
MDS1/EVI1; ES cells; 3q26; AML; megakaryocytic differentiation;
D O I
暂无
中图分类号
学科分类号
摘要
Chromosome band 3q26 is the locus of two genes, MDS1/EVI1 and EVI1. The proteins encoded by these genes are nuclear factors each containing two separate DNA-binding zinc finger domains. The proteins are identical, aside from the N-terminal extension of MDS1/EVI1, which is missing in EVI1. However, they have opposite functions as transcription factors. In contrast to MDS1/EVI1, EVI1 is often activated inappropriately by chromosomal rearrangements at 3q26 leading to inappropriate expression of the protein in hematopoietic cells and to myeloid leukemias, which are often characterized by abnormal megakaryopoiesis. We previously showed that the two proteins affect replication and differentiation of progenitor hematopoietic cell lines in opposite ways: whereas EVI1 inhibits the response of 32Dc13 cells to G-CSF and TGFβ1, MDS1/EVI1 has no effect on the G-CSF-induced differentiation of the 32Dc13 cells, and it enhances the growth-inhibitory effect of TGFβ1. In the present study, we analyzed the endogenous expression of the two genes during in vitro hematopoietic differentiation of murine embryonic stem (ES) cells and evaluated the effects of their forced expression on the ability of ES cells to produce differentiated hematopoietic colonies. We found that the expression of the two genes is independently and tightly controlled during differentiation. In addition, the forced expression of EVI1 led to a much higher rate of cell growth before and during differentiation, whereas the expression of MDS1/EVI1 repressed cell growth and strongly reduced the number of differentiated hematopoietic colonies. Finally, our study also found that the forced expression of EVI1 resulted in the differentiation of abnormally high numbers of megakaryocytic colonies, thus providing one of the first experimental models showing a clear correlation between inappropriate expression of EVI1 and abnormalities in megakaryopoiesis.
引用
收藏
页码:1639 / 1645
页数:6
相关论文
共 45 条
  • [1] Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements
    Sitailo, S
    Sood, R
    Barton, K
    Nucifora, C
    LEUKEMIA, 1999, 13 (11) : 1639 - 1645
  • [2] Analysis of EVI1 Gene Expression in Acute Myeloid Leukemia Patients in the Northeast of Iran
    Sadeghian, Mohammad-Hadi
    Ayatollahi, Hosein
    Shams, Seyyede-Fatemeh
    Dezaki, Zahra Rezaei
    MIDDLE EAST JOURNAL OF CANCER, 2019, 10 (04) : 305 - 313
  • [3] Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis
    Wu, Xia
    Wang, Huifang
    Deng, Jili
    Zheng, Xue
    Ling, Yantao
    Gong, Yuping
    ANNALS OF HEMATOLOGY, 2019, 98 (11) : 2485 - 2496
  • [4] EVI1 expression,clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia
    何雪峰
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (01) : 55 - 56
  • [5] High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
    Zheng, Yongzhi
    Huang, Yan
    Le, Shaohua
    Zheng, Hao
    Hua, Xueling
    Chen, Zaisheng
    Feng, Xiaoqin
    Li, Chunfu
    Zheng, Mincui
    Xu, Honggui
    He, Yingyi
    He, Xiangling
    Li, Jian
    Hu, Jianda
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia
    Vazquez, Iria
    Maicas, Miren
    Cervera, Jose
    Agirre, Xabier
    Marin-Bejar, Oskar
    Marcotegui, Nerea
    Vicente, Carmen
    Lahortiga, Idoya
    Gomez-Benito, Maria
    Carranza, Claudia
    Valencia, Ana
    Brunet, Salut
    Lumbreras, Eva
    Prosper, Felipe
    Gomez-Casares, Maria T.
    Hernandez-Rivas, Jesus M.
    Calasanz, Maria J.
    Sanz, Miguel A.
    Sierra, Jorge
    Odero, Maria D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (10): : 1448 - 1456
  • [7] A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells
    Cardona, Maria E.
    Simonson, Oscar E.
    Oprea, Iulian I.
    Moreno, Pedro M. D.
    Silva-Lara, Maria F.
    Mohamed, Abdalla J.
    Christensson, Birger
    Gahrton, Gosta
    Dilber, M. Sirac
    Smith, C. I. Edvard
    Arteaga, H. Jose
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 183 - 192
  • [8] Deletion of sequences telomeric of the EVl1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia
    Wieser, R
    Lechner, K
    Valent, P
    Fonotsch, C
    HAEMATOLOGICA, 2003, 88 (12) : 1427 - 1429
  • [9] The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain
    La Manna, Sara
    Scognamiglio, Pasqualina Liana
    Roviello, Valentina
    Borbone, Fabio
    Florio, Daniele
    Di Natale, Concetta
    Bigi, Alessandra
    Cecchi, Cristina
    Cascella, Roberta
    Giannini, Cinzia
    Sibillano, Teresa
    Novellino, Ettore
    Marasco, Daniela
    FEBS JOURNAL, 2019, 286 (12) : 2311 - 2328
  • [10] Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription
    Maicas, M.
    Vazquez, I.
    Vicente, C.
    Garcia-Sanchez, M. A.
    Marcotegui, N.
    Urquiza, L.
    Calasanz, M. J.
    Odero, M. D.
    ONCOGENE, 2013, 32 (16) : 2069 - 2078